What Causes Muscle Loss? Signs and Treatment

What causes muscle loss is a question relevant to people of all ages, though the answer involves far more than simply not exercising enough. Muscle wasting occurs when protein breakdown outpaces protein synthesis within skeletal muscle, and this imbalance can be driven by ageing, poor nutrition, physical inactivity, hormonal changes, systemic inflammation, certain medical conditions, and some prescribed medicines. Understanding these causes is the first step towards preventing or reversing muscle loss, and this article explains the key mechanisms, warning signs, and evidence-based approaches to diagnosis and treatment available through the NHS.

What actually causes muscle loss in the body?

Muscle loss occurs when protein breakdown exceeds synthesis, triggered by inactivity, poor nutrition, hormonal decline, inflammatory cytokines, certain medicines such as corticosteroids, and chronic illness.

Muscle loss occurs when the rate of muscle protein breakdown exceeds the rate of muscle protein synthesis, creating a negative protein balance within skeletal muscle tissue. This imbalance can be triggered by a wide range of factors, including inadequate nutrition, physical inactivity, hormonal changes, systemic inflammation, certain diseases, and some medicines. Understanding the underlying mechanism helps explain why muscle loss is not simply a matter of not exercising enough.

At a cellular level, muscle fibres are maintained through a continuous cycle of breakdown and rebuilding, regulated by signalling pathways such as the mTOR (mechanistic target of rapamycin) pathway. When anabolic signals, including insulin, insulin-like growth factor 1 (IGF-1), and mechanical load from exercise, are reduced, catabolic processes take over. In the context of chronic illness or systemic inflammation, inflammatory cytokines such as tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 can further accelerate protein degradation; this effect is most pronounced in conditions associated with persistent inflammation rather than in healthy individuals.

Hormonal shifts play a significant role as well. Declining levels of testosterone, oestrogen, and growth hormone, all of which occur naturally with age, reduce the body's capacity to synthesise new muscle protein. Elevated cortisol, the body's primary stress hormone, also promotes muscle breakdown, which is why prolonged physical or psychological stress can contribute to muscle wasting over time.

Certain medicines and substances can also contribute to muscle loss. Prolonged use of systemic corticosteroids is a well-recognised cause of steroid myopathy.^[10][11] Statin-associated muscle symptoms (SAMS) range from mild myalgia to, rarely, more significant muscle damage.^[13][14] Excessive alcohol intake is associated with alcoholic myopathy. Some antiretroviral medicines used in HIV treatment have also been linked to changes in muscle and body composition. If you are taking any prescribed medicine and are concerned it may be affecting your muscles, speak to your GP or pharmacist before making any changes, as stopping medicines without medical advice can be harmful.

Muscle loss is rarely caused by a single factor in isolation. Most people who experience significant wasting have a combination of contributing causes, and identifying the primary driver is essential for choosing the most effective approach to treatment or prevention.

Which medical conditions are linked to muscle wasting?

Sarcopenia, cachexia, motor neurone disease, Cushing's syndrome, poorly controlled diabetes, inflammatory myopathies, and chronic liver disease are all directly linked to accelerated muscle wasting.

Several medical conditions are directly associated with accelerated muscle wasting, with the most clinically significant being sarcopenia, cachexia, and myopathies. Sarcopenia refers specifically to age-related muscle loss, while cachexia is a complex metabolic syndrome seen in chronic illnesses such as cancer, heart failure, chronic kidney disease, and chronic obstructive pulmonary disease (COPD). Both conditions involve systemic inflammation and altered protein metabolism that go beyond simple disuse.

Neurological conditions can also cause profound muscle wasting by disrupting the nerve signals that maintain muscle tone and function. Motor neurone disease (MND) and spinal muscular atrophy lead to denervation atrophy, where muscles waste because they are no longer receiving adequate neural stimulation. Multiple sclerosis can result in muscle wasting too, though this is typically secondary to reduced activity and disuse rather than direct denervation. Conditions that cause prolonged immobility, such as stroke or spinal cord injury, also result in rapid disuse atrophy.

Endocrine disorders are another important category. Both hypothyroidism and hyperthyroidism are associated with muscle weakness and wasting. Cushing's syndrome, characterised by chronically elevated cortisol, and poorly controlled type 2 diabetes are also linked to reduced muscle mass. In diabetes, insulin resistance impairs the anabolic signalling needed for muscle protein synthesis, while hyperglycaemia can promote inflammatory pathways that accelerate breakdown. Chronic liver disease can impair protein synthesis and is an underrecognised cause of muscle wasting.

Autoimmune conditions, including rheumatoid arthritis, lupus, and inflammatory myopathies such as polymyositis and dermatomyositis, cause muscle damage through immune-mediated inflammation. Medication-induced myopathy, most commonly from prolonged corticosteroid use or statins, is also an important and treatable cause. Alcohol-related myopathy and muscle changes associated with HIV are further conditions worth considering in the appropriate clinical context.

Some symptoms require prompt medical attention rather than a routine GP appointment. Seek same-day urgent assessment or go to your nearest emergency department if you experience any of the following: sudden or rapidly progressive muscle weakness; difficulty swallowing or speaking; breathing difficulty; new foot drop or loss of limb function; or severe muscle pain accompanied by dark or cola-coloured urine, which may indicate rhabdomyolysis, a serious condition requiring urgent treatment.

If you notice unexplained muscle weakness or gradual loss of muscle bulk alongside other symptoms such as fatigue, joint pain, or unintentional weight loss, speak to your GP, as these may indicate an underlying condition requiring investigation. Unintentional weight loss with other concerning features should be assessed promptly, in line with NICE guidance on suspected cancer recognition and referral (NICE NG12).^[2][3]

How do age, diet, and inactivity speed up muscle loss?

Adults lose 3% to 8% of muscle mass per decade after age 30; ageing reduces anabolic hormone levels and protein sensitivity, while inactivity removes the primary stimulus for muscle protein synthesis.

Ageing is one of the most consistent drivers of muscle loss, with adults typically losing between 3% and 8% of muscle mass per decade after the age of 30, with the rate accelerating further after 60.^[1] This age-related decline, known as sarcopenia, results from a combination of reduced anabolic hormone levels, decreased sensitivity to dietary protein, lower physical activity, and chronic low-grade inflammation sometimes referred to as "inflammageing". The European Working Group on Sarcopenia in Older People (EWGSOP2) and the British Geriatrics Society both recognise sarcopenia as a clinically significant condition warranting structured assessment and management.^[1]

Dietary inadequacy compounds the problem significantly. Skeletal muscle requires a sufficient supply of dietary protein to support ongoing repair and synthesis. The standard UK reference nutrient intake for protein is 0.75 g per kilogram of body weight per day, but evidence from ESPEN (the European Society for Clinical Nutrition and Metabolism) and EWGSOP2 suggests that older adults and those at risk of muscle loss may benefit from higher intakes, as ageing reduces the muscle's anabolic response to protein, a phenomenon known as anabolic resistance.^[19][1] Deficiencies in vitamin D, which supports muscle function and neuromuscular signalling, are common in the UK population. The Scientific Advisory Committee on Nutrition (SACN) Vitamin D and Health report (2016) and NHS guidance both recommend that adults in the UK consider a daily vitamin D supplement, particularly during autumn and winter, and this is especially relevant for those with limited sun exposure or reduced mobility.^[7][8]

Physical inactivity is perhaps the most modifiable risk factor. Even short periods of bed rest or immobilisation, such as those following surgery or acute illness, can cause measurable muscle loss within days. Resistance exercise is the most effective stimulus for muscle protein synthesis, and its absence removes the primary anabolic signal that counteracts the body's natural catabolic processes. The UK Chief Medical Officers' Physical Activity Guidelines recommend that adults undertake muscle-strengthening activities on at least two days per week.

The three factors of age, poor diet, and inactivity interact in a self-reinforcing cycle: weaker muscles make activity harder, reduced activity leads to further loss, and appetite often declines with age, reducing protein intake further.

What are the warning signs that you are losing muscle mass?

Key warning signs include unexplained weakness, reduced grip strength, unintentional weight loss, slower walking speed, balance difficulties, and frequent falls, even when overall body weight remains stable.

Unexplained weakness, particularly difficulty with tasks that were previously straightforward such as climbing stairs, rising from a chair, or carrying shopping, is one of the most telling early warning signs of muscle loss. Many people attribute these changes to general tiredness or ageing without recognising them as indicators of declining muscle mass. Paying attention to functional changes, rather than appearance alone, is important for early identification.

Other common signs include:

• Reduced grip strength, which is used clinically as a proxy measure for overall muscle mass and has been associated with poorer health outcomes in older adults in multiple large studies^[1]

• Unintentional weight loss, particularly when accompanied by a visible reduction in limb circumference or muscle definition

• Increased fatigue during everyday activities, reflecting reduced muscular endurance

• Slower walking speed or balance difficulties, which are recognised markers of sarcopenia in clinical assessment frameworks including the EWGSOP2 diagnostic algorithm

• Frequent falls, which may indicate that lower limb muscle strength has declined to a point where postural stability is compromised

The SARC-F questionnaire is a validated screening tool used in primary care to identify people who may be at risk of sarcopenia; a positive result indicates the need for further clinical assessment rather than confirming a diagnosis on its own.^[20][21]

It is also worth noting that muscle loss can occur even when overall body weight remains stable, as fat mass may increase while lean mass decreases, a pattern sometimes called sarcopenic obesity. This makes the scales an unreliable sole indicator of muscle health.

If you experience sudden or rapidly progressive weakness, difficulty swallowing or breathing, new neurological symptoms, or severe muscle pain with dark urine, seek urgent medical attention the same day or go to your nearest emergency department. For less acute but persistent concerns, particularly if several of the signs above have developed over a relatively short period or are accompanied by breathlessness, persistent fatigue, or joint swelling, contact your GP for assessment rather than assuming the changes are simply a normal part of getting older.

How is muscle loss diagnosed and treated on the NHS?

NHS diagnosis combines clinical assessment, grip strength and walking speed tests, the SARC-F questionnaire, and blood tests; treatment focuses on addressing the root cause, resistance exercise, and nutritional support.

Muscle loss is diagnosed on the NHS through a combination of clinical assessment, functional tests, and, where appropriate, imaging or blood tests to identify underlying causes. GPs will typically begin with a detailed history and physical examination, assessing grip strength, walking speed, and the ability to perform tasks such as rising from a seated position. The SARC-F questionnaire is a validated screening tool that may be used in primary care to identify patients at risk of sarcopenia, with further assessment guided by the EWGSOP2 diagnostic framework.^[20][21]

Blood tests can help identify contributing factors, including:

• Full blood count and inflammatory markers (CRP, ESR) to detect systemic inflammation or anaemia

• Thyroid function tests to assess both hypothyroidism and hyperthyroidism

• Vitamin D and calcium levels, given the high prevalence of deficiency in the UK

• HbA1c to assess glycaemic control in patients with or at risk of diabetes

• Creatine kinase (CK) if an inflammatory myopathy or medication-induced muscle damage is suspected

• Urea, electrolytes, and estimated glomerular filtration rate (eGFR) to assess kidney function

• Liver function tests, particularly where chronic liver disease or alcohol-related causes are possible

• Vitamin B12 and folate, as deficiencies can contribute to weakness and fatigue

• Cortisol if Cushing's syndrome is suspected

A medication review is an important part of the assessment, as prolonged corticosteroid use, statins, and some other medicines can contribute to muscle loss.

DEXA (dual-energy X-ray absorptiometry) scanning can provide an accurate measure of lean muscle mass and is available in some NHS settings, though access varies by Integrated Care Board (ICB). Bioelectrical impedance analysis (BIA) and calf circumference measurement are alternative body composition assessment methods recognised by EWGSOP2, and may be more widely available. Referral to a geriatrician, rheumatologist, or neurologist may be arranged depending on the suspected underlying cause. NHS community physiotherapy and falls prevention services can also provide structured support.

Treatment on the NHS is largely focused on addressing the root cause alongside structured physiotherapy and nutritional support. NICE guidance on falls prevention and frailty emphasises resistance exercise and adequate protein intake as first-line interventions. There are currently no medicines licensed in the UK specifically for sarcopenia, though conditions such as vitamin D deficiency or hypothyroidism that contribute to muscle loss are treated with standard pharmacological approaches.^[12] Bolt Pharmacy is a GPhC-registered online pharmacy in Great Britain offering online consultations, with prescriber review and pharmacist support, and may be one option for those seeking assessment alongside their NHS care.

Can you rebuild lost muscle, and how long does it take?

Lost muscle can be rebuilt at any age with consistent resistance exercise and adequate protein intake; younger adults may see measurable gains within eight to twelve weeks, while older adults typically require several months.

Lost muscle can be rebuilt in most people, provided the underlying cause is addressed and an appropriate programme of resistance exercise and nutritional support is followed consistently. The capacity for muscle regrowth, known as muscle hypertrophy, is retained throughout life, though it is slower and requires greater effort in older adults due to anabolic resistance and lower baseline hormone levels. Research consistently shows that even people in their 70s and 80s can achieve meaningful gains in muscle mass and strength with structured training.

The timeline for rebuilding muscle depends on several factors, including the degree of loss, the individual's age and health status, the quality of their nutrition, and the consistency of their exercise programme. In younger, otherwise healthy adults recovering from a period of immobilisation, noticeable strength improvements can occur within four to six weeks of resuming resistance training, with measurable increases in muscle mass typically evident within eight to twelve weeks. In older adults or those recovering from serious illness, progress is generally slower and may take several months of sustained effort.

Key principles for effective muscle rebuilding include:

• Progressive resistance exercise, such as weight training, bodyweight exercises, or resistance band work, performed at least two to three times per week, in line with the UK Chief Medical Officers' Physical Activity Guidelines

• Adequate protein intake, distributed evenly across meals; ESPEN and EWGSOP2 guidance supports intakes of around 1.2 to 1.6 g per kilogram of body weight per day for older adults and those actively trying to rebuild muscle, with protein spread across meals to maximise the anabolic response

• Sufficient energy intake to support anabolism, as a significant calorie deficit will impair muscle protein synthesis

• Vitamin D supplementation if levels are low, as this supports neuromuscular function, in line with SACN and NHS recommendations

If you have significant comorbidities, frailty, or a high falls risk, seek clinical advice before starting a new resistance training programme, as your GP or physiotherapist can help identify the most appropriate and safe approach for your circumstances. For those without specific health concerns, asking your GP for a referral to a physiotherapist or exercise specialist is a good starting point.

Scientific References

1. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2).
2. Suspected cancer: recognition and referral (NG12).
3. NG12 – Unexplained weight loss as a non-site-specific symptom in adults in primary care.
4. NG12 – Recommendations organised by site of cancer.
5. UK Chief Medical Officers' Physical Activity Guidelines.
6. Physical activity guidelines for adults aged 19 to 64.
7. SACN Vitamin D and Health report.
8. Fortifying foods and drinks with vitamin D: main report.
9. Appendix A PH56 Vitamin D: increasing supplement use – summary of new evidence from surveillance.
10. Kenalog Intra-articular / Intramuscular Injection – Summary of Product Characteristics.
11. The effect of corticotherapy on respiratory muscles.
12. Current and investigational medications for the treatment of sarcopenia.
13. Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management.
14. Use of mobile health technology in the assessment of statin-associated muscle symptoms: a pilot feasibility study.
15. Patient-reported muscle symptoms and their characterization in a hypertensive population eligible for statin therapy.
16. Inflammation and inflammatory cytokines in cardiac cachexia: an incendiary issue.
17. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation.
18. Endoplasmic reticulum stress, calcium dysregulation and altered protein translation: intersection of processes that contribute to cancer cachexia induced skeletal muscle wasting.
19. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group.
20. Diagnostic accuracy of the SARC-F questionnaire in Argentine older adults.
21. Enhancing sarcopenia screening in primary care: a machine learning approach using simple physical tests vs. SARC-F in 2,788 community-dwelling older adults.
22. Screening and diagnosis tools for sarcopenia: an overview of systematic reviews.
23. Emerging Myostatin and Metabolic Hormone Pathway Modulators in Cardiometabolic Disease: Mechanisms, Evidence, and Therapeutic Potential.
24. Genomic and epigenetic regulatory mechanisms in exercise-based rehabilitation processes: cellular and tissue remodeling, microvascular adaptation, and circulating biomarkers.

Frequently Asked Questions